Dow Down 0.92% Nasdaq Down 0.83%

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
1.18 Oct 22, 4:00PM EDT
Prev Close:1.18
Open:1.21
Bid:N/A
Ask:3.18 x 2000
1y Target Est:3.24
Beta:2.55
Next Earnings Date:N/A
Day's Range:1.17 - 1.22
52wk Range:0.82 - 1.74
Volume:802,538
Avg Vol (3m):1,064,260
Market Cap:68.31M
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEZS

Comparison

Symbol% ChgMkt Cap
AEZS 0.00%68.31M
CELG75.76B
ENMDN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,018.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.59
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback